for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Shandong Xinhua Pharmaceutical Co

000756.SZ

Latest Trade

9.86CNY

Change

-0.53(-5.10%)

Volume

13,919,687

Today's Range

9.75

 - 

10.33

52 Week Range

7.32

 - 

12.62

As of on the Shenzhen Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
10.39
Open
10.25
Volume
13,919,687
3M AVG Volume
376.08
Today's High
10.33
Today's Low
9.75
52 Week High
12.62
52 Week Low
7.32
Shares Out (MIL)
632.54
Market Cap (MIL)
5,044.56
Forward P/E
--
Dividend (Yield %)
1.52

Next Event

Q4 2021 Shandong Xinhua Pharmaceutical Co Ltd Earnings Release

Latest Developments

更多

Shandong Xinhua Pharmaceutical Posts 9-Mths Net Profit Attributable RMB285.3 Million

Shandong Xinhua Pharmaceutical Says To Issue 36.3 Million A Shares To Hualu Investment

Shandong Xinhua Pharmaceutical Says Well Bring Further Bought 1.8 Mln H Shares Of Co

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Shandong Xinhua Pharmaceutical Co

SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED is a China-based company principally engaged in the development, production and distribution of chemical bulk drugs, preparations and medical intermediates. The Company’s main products include metamizole sodium, caffeine, aminopyrine, aspirin, hydrocortisone, pipemidic acid, ibuprofen, L-dopa, pipemidic acid tablets, compound liquorice tablets and nimodipine tablets. The Company distributes its products in domestic market and to overseas markets, including the Americas, Europe and others.

Industry

Biotechnology & Drugs

Contact Info

No.1 Lutai Avenue, High-tech Zone

ZIBO, SDG

255086

China

+86.533.2166666

http://www.xhzy.com

Executive Leadership

Daiming Zhang

Executive Chairman of the Board

Ning Hou

Chief Financial Officer

Tongqing He

Deputy General Manager, Executive Director

Deqing Du

Deputy General Manager

Changsheng Wei

Deputy General Manager

Key Stats

Price To Earnings (TTM)
17.19
Price To Sales (TTM)
0.80
Price To Book (MRQ)
1.82
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
45.59
LT Debt To Equity (MRQ)
10.54
Return on Investment (TTM)
8.33
Return on Equity (TTM)
5.43

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up